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ABSTRACT 
Purpose 
There is considerable between subject variation in retinal ganglion cell (GC) density in 
healthy individuals, making identification of change from normal to glaucoma difficult. 
Ascertaining local cone:GC density ratios in healthy individuals, we wished to 
investigate the utility of objective cone density estimates as a surrogate of baseline GC 
density in glaucoma patients, and thus a more efficient way of identifying early 
changes.  
 
Design 
Exploratory cohort study. 
 
Participants 
Twenty glaucoma patients (60% female) with a median age of 54 years and mean 
deviation (MD) in the visual field (VF) of -5 dB and 20 healthy controls (70% female) 
with a median age of 57 years and MD of 0 dB were included. 
 
Methods  
Glaucoma patients and healthy subjects underwent in vivo cone imaging at 4 locations 
of 8.8° eccentricity with a modified Heidelberg Retina Angiograph HRA2 (scan angle 
of 3°). Cones were counted using an automated programme. GC density was 
estimated at the same test locations from peripheral grating resolution acuity (PGRA) 
thresholds. 
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Main Outcome Measures 
Retinal cone density, estimated GC density and cone:GC ratios in glaucoma patients 
and healthy controls. 
 
Results 
Median [interquartile range, IQR] cone:GC density was 3.51:1 [2.59:1, 6.81:1] in 
glaucoma patients compared to 2.35:1 [1.83:1, 2.82:1] in healthy subjects . GC density 
was 33% lower in glaucoma patients than in healthy subjects, however cone density 
was very similar in glaucoma patients (7,248 cells/mm²) and healthy controls (7,242 
cells/mm²).The area under the receiver operator characteristic curve was 0.79 (95% 
confidence interval [CI] 0.71-0.86, P<0.001) for both GC density and cone:GC ratio, 
and 0.49 (95% CI 0.39-0.58, P=0.79) for cone density. 
 
Conclusions 
Local measurements of cone density do not differ significantly from normal in glaucoma 
patients despite large differences in GC density. There was no statistically significant 
association between GC density and cone density in the normal participants, and the 
range of cone:GC density ratios was relatively large in healthy controls. These findings 
suggest that estimates of baseline GC density from cone density are unlikely to be 
precise, and offer little advantage over determination of GC alone in the identification 
of early glaucomatous change. 
 
Key words 
Retinal cone mosaic, glaucoma, ganglion cell density, psychophysics, cone imaging, 
Heidelberg Retina Angiograph   
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Introduction 
Between-individual variability in retinal ganglion cell (GC) density in healthy human 
eyes is known to be high.1 As a result, when a patient suspected of having glaucoma 
presents for the first time, it is difficult to determine whether a clinical measurement 
relating to GC density (e.g., conventional perimetry, peripheral grating resolution acuity 
[PGRA], or imaging parameter) is normal for the individual or already represents a 
change from that individual’s original baseline. If, however: a) the cone:GC ratio is 
relatively similar between normal individuals (despite large inter-individual variation in 
both cone and GC density), and b) the number of cones remains stable in glaucoma 
(despite a decline in GC density), then objective cone density measures could be used 
as a means to determine the original baseline GC density and thus help to identify 
early GC loss in glaucoma without a lengthy longitudinal investigation.  
While the death of retinal GC is a hallmark of glaucoma, the notion of a loss of 
cones in glaucoma is somewhat controversial. A loss of cones has been reported in 
several studies2-5, but this has not been confirmed in other studies.6, 7 With the 
introduction and development of adaptive optics (AO) technology, in vivo imaging of 
retinal structures at cellular level has become possible.8 More recently, Wolsley et al 
demonstrated that, by  narrowing the scan width of the Heidelberg Retina Tomograph 
(HRT), the parafoveal photoreceptor mosaic may be imaged in vivo with a 
commercially available clinical device, without the need for AO.9 Similarly, images of 
the retinal cones can also be obtained in vivo using a modified Heidelberg Retina 
Angiograph 2 (HRA2), in a patient-friendly clinical setting.   
In this study we used measurements of PGRA10 to estimate GC density at 
various locations outside the fovea. We also used a modified, small-angle HRA2 to 
image retinal cones in vivo at the same locations. By separately measuring cone and 
GC density at identical locations in both healthy subjects and glaucoma patients we 
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wished to a) explore the possibility of estimating what was the local baseline GC 
density in glaucoma patients from in vivo measurements of cone density using normal 
cone:GC density ratios , b) establish between-individual variability in cone:GC density 
in healthy observers, and c) investigate the utility of cone:GC density ratios in the 
identification of glaucoma. 
 
Methods 
Participants 
The study protocol was approved by both the relevant National Health Service 
Research Ethics Committee and the UCL Research Ethics Committee. The research 
followed the tenets of the Declaration of Helsinki and written informed consent was 
obtained from all participants prior to inclusion. 
 Twenty open-angle glaucoma patients with a median age of 54 years and mild 
to moderate, mainly localized, visual field loss (median [IQR]: mean deviation (MD), -
5 dB [-9, -4]; pattern standard deviation (PSD), 8 dB [6, 10]), and 20 age-similar healthy 
controls with a median age of 57 years underwent in vivo cone imaging with a HRA2 
in addition to co-localized estimates of PGRA and differential light sensitivity (DLS). 
Inclusion criteria for glaucoma patients were: a diagnosis of open-angle glaucoma 
(including normal tension glaucoma), ‘outside normal limits’ readings for optic disc 
imaging according to Moorfields Regression Analysis using Heidelberg Retina 
Tomograph (HRTII; Heidelberg Engineering GmbH, Heidelberg, Germany) and overall 
or focal loss of peripapillary retinal nerve fibre layer (RNFL) in optical coherence 
tomography imaging (Spectralis OCT, Heidelberg Engineering GmbH, Heidelberg, 
Germany), in addition to a confirmed glaucomatous visual field defect as determined 
by standard automated perimetry (SAP) with the Humphrey Field Analyzer (HFAII; Carl 
Zeiss Meditec, Dublin, CA) 24-2 Swedish Interactive Threshold Algorithm (SITA) 
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strategy. A glaucomatous visual field defect was defined as a reduction in sensitivity 
at two or more contiguous locations with P < 0.01 loss or more, three or more 
contiguous points with P < 0.05 loss or more.11 Inclusion criteria for healthy subjects 
were ‘within normal limits’ results for optic disc imaging (HRTII and OCT) and a full 
visual field. Subjects with a reliable visual field with fewer than 30% fixation losses and 
less than a 15% false-positive rate were included. All subjects had intraocular pressure 
(IOP) <21 mmHg, refractive error <6.00 DS and <1.50 DC, and visual acuity (VA) of 
20/30 (6/9) or better in the test eye, in the absence of significant corneal or media 
opacities. Exclusion criteria were the evidence of any systemic disease or medication 
which affects visual performance (e.g. diabetes, thyroid disease), any ocular disease 
(other than glaucoma for the glaucoma group), and surgery that may affect visual 
performance (e.g. resulting in poor visual acuity, refractive error outside above stated 
range). 
 After completion of preliminary tests, in vivo cone imaging with a modified small-
angle HRA2, localized measurements of DLS and PGRA to estimate GC density, and 
thickness measurement of the ganglion cell layer (GCL) were performed as described 
below. One experienced operator (JM) performed all tests. If both eyes met inclusion 
and exclusion criteria in glaucoma patients and normal controls, the right eye was 
chosen.  
 
Psychophysical tests 
Peripheral Grating Resolution Acuity (PGRA) 
PGRA was measured in the corresponding visual field locations with achromatic Gabor 
patches in sine phase (SD x Spatial frequency: 4; Michelson contrast: 99%; mean 
luminance: 30 cd/m2), presented on a uniform 30 cd/m2 grey background varying in 
spatial frequency. Experiments were undertaken on a gamma-corrected Phillips FIMI 
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MGD-403 Achromatic CRT monitor (Ampronix, Irvine, CA, USA; refresh rate: 80 Hz, 
pixel resolution: 976 x 1028), driven by a Visual Stimulus Generator (ViSaGe MKII, 
Cambridge Research Systems, Rochester, UK) and the Cambridge Research Systems 
(CRS) toolbox (version 1.27) for MATLAB (R2014b, The MathWorks Inc., Natick, MA). 
Reponses were collected using a Cedrus RB-530 response box (Cedrus Corporation, 
San Pedro, CA, USA). Participants were asked to view a cross-hair fixation target on 
the CRT monitor at a viewing distance of 60 cm and report whether the grating, 
presented at 8.8° eccentricity along the 45°, 135°, 225° and 315° meridians for 500 
ms, was orientated either horizontally (180º) or vertically (90º). Resolution acuity was 
determined using a 3/1 reversal strategy, taking the average of four reversals, where 
the first two reversals resulted in a spatial frequency change of 20%, the third reversal 
a 10% change and the final reversal 5% change. Gabor patches scaled in size to 
maintain a constant number of high contrast cycles within the patch at all times to 
optimize resolution performance.12 All subjects were optically corrected for the test 
distance and the eye not being tested was occluded. Resolution acuity values were 
then converted from minimum angle of resolution (MAR) to GC density (D, in GC/mm2) 
using the equation MAR = 0.93/√D for a hexagonal array.13 A conversion factor from 
Drasdo & Fowler14 was used to calculate the number of GCs per square millimeter of 
the retina. 
 
Differential light sensitivity (DLS) 
Contrast thresholds were measured for an approximate Goldmann III size achromatic 
stimulus (0.48°, 0.18 deg2) of duration15 191.9 ms at the same visual field locations 
(8.8° eccentricity along the 45°, 135°, 225° and 315° meridians). Stimuli were 
generated with a ViSaGe MKII and the CRS toolbox for MATLAB. Participants were 
instructed to view the central fixation target and press a button on a response pad 
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(Cedrus RB-530) when a stimulus was seen. A randomly interleaved 1/1 staircase 
(step size 0.5 dB of the previous value) terminating after six reversals was used, with 
threshold contrast being calculated as the mean of the final four reversals. Contrast 
thresholds were expressed in Humphrey equivalent dB values. 
 
In vivo cone imaging using a modified small-angle HRA2 
A standard HRA2 (Heidelberg Engineering GmbH, Heidelberg, Germany) was 
modified for high resolution imaging of the fundus. For this purpose the scan angle was 
reduced by a factor of 10x to image fields of view of 3°, 2° and 1.5°, while the total 
number of pixels remained unchanged. This resulted in an oversampling of the 
diffraction limited spot size with the cone mosaic becoming visible (Fig 1 A, B). The 
images were acquired using a diode laser emitting at 815 nm working under reflection 
mode. The laser power was confirmed to be safe without restrictions, according to 
International Electrotechnical Commission (IEC) 60825-1:2007. To assess different 
areas of the fundus, the internal fixation lights could be adjusted manually by means 
of externally accessible alignment tools. In vivo imaging of the retinal cone mosaic was 
performed at four retinal locations (inferior nasal, inferior temporal, superior nasal, 
superior temporal retina) at 8.8° eccentricity along the 45°, 135°, 225° and 315° retinal 
meridians, through undilated pupils with room lights on (Fig 1 C, D). Subjects were 
instructed to look at the center of one of the cross-hair fixation targets, positioned at 
one of four pre-determined locations relative to the scan window, to enable imaging at 
the desired locations. Single, non-averaged en face reflectance images were collected 
and analyzed. The field of imaging was 3° × 3°, equating to 0.825 x 0.825 mm on the 
retina, based on Drasdo and Fowler’s conversion for the relevant retinal location.14  
 
 
10 
 
Image analysis  
Raw images of the cone mosaic (~3° x 3°, 768 x 768 pixels) were initially cropped to 
remove any extraneous features (e.g., scale bar, company logo, etc.). Cones were 
then identified in the cropped image (~2.89° x 2.89°, 740 x 740 pixels) by the method 
of Li & Roorda16, in MATLAB (R2014b) with the image processing toolbox (IPT). Briefly, 
this analysis first applies a low-pass filter in the frequency domain to the image to 
remove high-frequency noise from the image. Following this, the image is converted 
back to the spatial domain and the local luminance maxima detected using the IPT 
function imregionalmax. These identified regions were assumed to be cone centers 
and were plotted as single white pixels on a black background. To ensure the identified 
cones were not closer than physiologically possible, the binary blobs were each dilated 
using a white disk of diameter 2 pixels (i.e., if inter-cone spacing were too small, the 
given identified cones would no longer be spatially independent following dilation). 
Following this, each remaining spatially independent blob was counted as a cone. This 
value was then converted to a density value expressed as cones/mm2. This method 
has been shown to provide cone density estimates that are very similar to those 
determined through manual counts, with the spatial localization of identified cones also 
being accurate for images acquired with AO technology.16 Figure 2 shows an example 
of the worst, typical and best quality image we captured in our participants and the 
automated cone count of the scan with the best quality. 
 
Ganglion cell layer thickness 
Automated segmentation and thickness measurement of the GCL was performed on 
the posterior pole scans (Spectralis OCT, acquisition software version 5.7.4.0). The 
grids on the posterior pole GCL thickness scans were rotated and translated to align 
with individual cone images (squares of grid also 3° × 3°, Fig 3). 
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Statistical analysis 
Statistical analyses were performed with SPSS 23 (IBM Corporation, Armonk, NY, 
USA) and R (version 3.0.0, The R project). Median [interquartile range, IQR] GC and 
cone densities (cells/mm²), and cone:GC ratios, were calculated for glaucoma patients, 
and compared with those in age-similar healthy controls. A Mann-Whitney U test was 
used to test for statistically significant differences between groups and Friedman’s two-
way analysis of variance between locations within groups. Linear regression analysis 
was used to investigate the relationship between cone and GC density, cone:GC ratio 
and GCL thickness (from OCT) to corresponding DLS values (expressed in Humphrey 
equivalent dB values). Cone and GC density and GCL thickness were converted to log 
values for comparison with DLS. Receiver operator characteristic (ROC) curves and 
associated area under the receiver operator characteristic curve curve (AUROC) 
values were used to compare cone:GC ratio, GC density and cone density for 
diagnostic accuracy in the detection of glaucoma. Sixty-nine of 80 locations in 
glaucoma patients and 75 of 80 locations in healthy controls were included in the 
analysis. Scans where no cones could be resolved by eye were excluded from 
analysis. Glaucoma was seen as the positive test result. The ROC curves were used 
to estimate the sensitivity of GC density and cone:GC ratio at set specificities of 80% 
and 90%. For all analyses listed, a P value of <0.05 was considered statistically 
significant. To avoid type I errors we performed a Holm-Bonferroni correction where a) 
there were multiple tests of the same hypothesis (e.g. testing statistical significance of 
differences between data in superior and inferior hemifields) and b) p-values for 
individual tests are less than 0.05.  
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Results 
General characteristics of glaucoma patients and age-similar healthy controls are 
given in Table 1. There was no statistically significant difference between each group 
in terms of age, gender, visual acuity, spherical refractive error or IOP (all P > 0.05).  
 
GC density, cone density and cone:GC ratio 
 Median GC density was 33% lower in glaucoma patients than in healthy 
subjects over all tested locations. GC density was significantly reduced in glaucoma 
patients compared to that in healthy controls in the inferior retinal hemified (P < 0.001, 
Table 2). Figure 4 shows the fundus image of a glaucoma patient with a paracentral 
scotoma in the superior visual field and corresponding reduced RNFL thickness and 
GC density in the inferior retina. 
There was no statistically significant difference in cone density between 
glaucoma patients and healthy controls in either retinal hemifield (superior: P = 0.48, 
inferior: P = 0.69). Median cone density was very similar between glaucoma patients 
and healthy controls (glaucoma patients: 7,248 cells/mm², healthy controls: 7,242 
cells/mm²; Table 2). There was no statistically significant inter-location difference in 
cone density within each group (glaucoma: P = 0.44; healthy controls: P = 0.75). 
 Cone density and GC density were not significantly associated in either 
hemifield in the healthy or glaucomatous  group (Fig 5 A, C). There was a statistically 
significant relationship between DLS and log estimated GC density in both retinal 
hemifields in glaucoma patients (superior: R² = 0.59, P < 0.001; inferior: R² = 0.28, P 
< 0.001, Fig 5 B, D). There was no statistically significant relationship between DLS 
and log cone density in either group.  
Median cone:GC density ratio was 3.51:1 (IQR: 2.59:1, 6.81:1) in glaucoma 
patients compared to 2.35:1 (IQR: 1.83:1, 2.82:1) in healthy subjects (Table 2, Fig 5 
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E). Ratios were significantly higher in the glaucoma patient group, compared to those 
in the healthy subject group (P < 0.01). Cone:GC ratios were not significantly different 
in the superior locations (without glaucomatous defect of the corresponding inferior 
hemifield) between glaucoma patients and healthy subjects (P > 0.05, Table 2). 
Cone:GC density ratios showed a large range in healthy controls (Fig 5 E). In view of 
this, attempting to calculate the true baseline GC density from in vivo measurements 
of cone density from healthy controls would be imprecise. The coefficient of variation 
was 30% for cone:GC ratio and 33% for GC density.  
 
Separation of cone:GC ratio and GC density to diagnose glaucoma 
Figure 6 illustrates the ROC curve for GC and cone density and cone:GC ratio. AUROC 
was 0.79 (95% confidence interval [CI] 0.71-0.86, P < 0.001) for both GC density and 
cone:GC ratio.Specificity was set to 80% and 90% and sensitivity was then derived. At 
a specificity of 80%, sensitivity was 62% for GC density (with cut-off value of 2,425 
GCs/mm²) and 59% for cone:GC ratio (with cut-off values of 3.04:1). At a set specificity 
of 90%, sensitivity was 44% for GC density (1,935 GCs/mm²) and 49% for cone:GC 
ratio (3.59:1). 
 
Ganglion cell layer thickness 
GCL thickness was reduced in glaucoma patients compared to healthy controls in the 
area corresponding to visual field defects. The greatest GCL thickness loss across all 
of our patients was in the inferior retina (corresponding to superior hemifield on visual 
field). Median GCL thickness at test locations in glaucoma patients was 23 µm, 
significantly thinner than that in healthy controls (31 µm, P < 0.001, Table 2). No 
correlation was found between cone density and GCL thickness at any location in 
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either group (Spearman’s ρ 0.02, P = 0.81). There was a significant linear relationship 
between DLS and GCL thickness (R² = 0.52, P < 0.001). 
 
Discussion 
The findings of this study lend support to the notion that although GC density is 
significantly reduced in glaucoma patients relative to that in healthy controls, cone 
density is not. The ratio of cones and overlying GCs is therefore increased in our 
participants with glaucoma. One of the aims of this study was determine the utility of 
cone imaging in the calculation of baseline GC density for more efficient identification 
of GC loss. The moderately large range of cone:GC density ratios in healthy controls 
(Fig 5 E) leads us to conclude that any prediction of baseline GC density from objective 
measures of cone density would be imprecise and offer little superiority over 
conventional methods in the identification of early glaucomatous loss.  
Despite finding no statistically significant difference in cone density overall in the 
glaucoma patients recruited to the current study, it was still considered possible that 
by combining information on local cone and GC density in each patient may offer 
advantages over and above density alone for the identification of glaucomatous retinal 
damage. However, we did not find a statistically significant relationship between cone 
and GC density in patients or controls. Furthermore, the qualitative and quantitative 
(AUROC) similarity in the ROC curves for cone:GC ratio and GC density alone, further 
demonstrates that there is little advantage in combining cone and GC density 
estimates in each patient.  
This is the first study to compare estimates of cone density, derived from in vivo 
images of the photoreceptor mosaic captured with an Heidelberg Retina Angiograph 2 
(HRA2) without adaptive optics (AO), and psychophysical estimates of ganglion cell 
density and function in corresponding regions. The retinal cone density agreed 
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reasonably well with previously published studies using histological data17, 18, AO 
imaging19-21 and imaging with a modified first-generation Heidelberg Retina 
Tomograph9.  
 Although glaucoma is a degenerative optic neuropathy affecting ganglion cells 
and their axons, previous studies investigating the involvement of the outer retina, 
including photoreceptors, in the disease have yielded somewhat conflicting results. 
Structural2-5 changes of the outer retina in glaucoma have been reported by some 
histological and clinical studies but not by others.6, 7 Studies involving tests of colour 
vision and electrophysiology have reported reduced function, suggestive of outer 
retinal layer abnormalities in glaucoma.22-27 Vincent et al have shown a dysfunction of 
cone photoreceptors in the central 24° visual field in advanced glaucoma using 
multifocal electroretinogram.27 Cone densities presented in our study were not 
significantly different between glaucoma patients with visual field loss ranging from 
mild to moderate and age-similar healthy controls. We have included predominantly 
glaucoma patients with paracentral defects (within 10° of fixation) but did not find cone 
loss at 8.8° in glaucoma. Choi and colleagues found evidence of cone loss in glaucoma 
using AO imaging.2 A shortening of the cone outer segments was seen with AO in 
areas corresponding to reduced visual sensitivity. The authors concluded that this may 
explain dark patches observed in AO en face retinal images. This is in line with a study 
conducted by Werner et al on outer retinal changes in glaucomatous and non-
glaucomatous optic neuropathies observing that cones were less reflective in 
corresponding areas of visual field defect, resulting in dark regions in the en face AO 
images and accompanying disruptions in the outer retinal layers.5 Although number of 
cones did not differ between areas of normal and depressed visual sensitivity among 
glaucoma patients, and also between healthy subjects and glaucoma patients in our 
study, we have seen dark areas where cones could not be resolved in a number of 
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patients. For example, they can be observed in the inferior retina corresponding to a 
dense superior hemifield defect in a 47 year-old glaucoma patient (Fig 7 as 
supplemental data).  
In this study, median cone density at 8.8° (2.42 mm) retinal eccentricity was 
7,248 cells/mm² in glaucoma patients and 7,242 cells/mm² in healthy controls . These 
cone density estimates are somewhat lower than those reported in some histological 
studies (e.g. Curcio et al17) or from some in vivo studies using AO imaging devices.19-
21 Curcio et al reported cone counts of approximately 9700 cones/mm² at ~ 2.5 mm 
retinal eccentricity in 8 eyes of 7 healthy, adult human donors (age 27-44 years).17 An 
AO imaging study conducted by Song and colleagues found a cone density of 
approximately 8600 cells/mm² at ~ 2.6 mm retinal eccentricity in healthy participants 
aged 22-65 years.21 Wolsely et al used a modified HRT to image cones in 2 healthy 
subjects and found a cone density of 7000 cones/mm² at ~ 2.3 mm eccentricity 
(extrapolated from values presented) and compares well to our data.9 However, Jonas 
et al reported a lower cone density of 6000 cones/mm² at only 1.5 mm (~ 5°) retinal 
eccentricity in 21 normal human donor eyes with a mean age of 47 ± 22 years (range 
2–90 years).18 Inter-study variations in the age and refractive error of participants, in 
addition to possible eccentricity changes as a result of flat-mounting in histological 
studies, may partially account for any differences in cone density reported in the 
literature with those in this study. Another potential source of variability influencing 
reported cone densities relate to the factor used for the conversion of millimetres to 
degrees on the retina, along with nuances in the analysis methods applied to generate 
cone counts. The algorithm used for automated cone counting in this study was, 
however, based on work previously reported for cone images with AO devices.16,20 
These reports found a good agreement between automated and manual counting 
analysis methods. 
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 Limitations of our study must be discussed. First, as this was an exploratory 
study, only a small number of participants was included. Second, while we did not 
adjust for GC displacement relative to their corresponding photoreceptors, the 
displacement of GCs decreases with eccentricity and is reported to be negligible (2.34 
mm) for cones at 2.42 mm (8.8°) eccentricity using the equation y = 1.29 x [x + 0.046]0.67 
(y = GC eccentricity; x = cone eccentricity) from Sjöstrand et al.28 Third, some images 
(11 of 80 glaucoma and 5 of 75 normal) were excluded from analysis where cones 
could not be identified, either owing to optical limitations (e.g. poor tear film, higher 
astigmatism or unsteady fixation) or some, as yet, unknown change in the retina (e.g. 
refractive index changes).  
 In conclusion, our results did not show any notable advantage in using cone: 
GC ratios over GC density alone for identifying glaucoma. Cone:GC density ratios and 
GC densities show a relatively large range even in healthy controls and no relationship 
was found between cone and GC density in either group. On this basis, we conclude 
that measurements of cone density are unlikely to be helpful in the estimation of local 
baseline GC density in a first-time patient.   
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FIGURE LEGENDS 
 
Figure 1. Schematic view of a Modified Heidelberg Retina Angiograph 2 (HRA2).  
A and B – Small-angle principle of a modified HRA2. Standard 30° (top) and modified 
small-angle 3° principle (bottom). In vivo cone imaging was performed at 4 retinal 
locations at approximately 8.8° retinal eccentricity.  
C and D – Small-angle retinal scan with a scan angle of 3° (cropped to ~2.89° x 2.89°, 
740 x 740 pixels) of a 58 year-old healthy control and superimposed onto fundus 
image. 
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Figure 2. Examples of cone scans. 
Worst (A), typical (B) and best quality (C) images of the retinal cone mosaic (D – 
automated cone count; note few cones were counted in blood vessels). All images 
were cropped to 740 x 740 pixels. 
 
 
 
 
 
 
23 
 
Figure 3. Adjustment of ganglion cell layer thickness measurement. 
A – False-color thickness map displays thickness measurement of ganglion cell layer 
(GCL).  
B – The posterior pole grid was subsequently adjusted such that the external border 
of the grid was parallel with the edge of the fundus image and the overlay transparency 
adjusted to visualize landmarks (e.g. blood vessels).  
C – The grid was then moved to coincide with the position as of the cone image(s) 
captured (D) to produce GCL thickness values in the retinal regions examined. 
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Figure 4. Fundus of a 60 year-old female patient with normal tension glaucoma. 
Inferior ganglion cell (GC) loss and corresponding superior field defect (pattern 
deviation plot). Reduced GC density and respective increased cone:GC ratio in the 
inferior retina. 
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Figure 5. Relationships between local cone density, ganglion cell (GC) density and 
differential light sensitivity (DLS).  
A, C – Relationship between local cone and GC density in the superior (A) and inferior 
(C) retinal hemifields of glaucoma patients and controls 
B, D – Relationship between local cell (cone and GC) density and differential light 
sensitivity (DLS) in glaucoma patients and controls. Boxes indicate the 95% confidence 
intervals for cell density (height) and DLS (width) in healthy controls. 
E – Range of cone:GC ratios in glaucoma patients and healthy controls. 
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Figure 6. Receiver operating characteristic (ROC) curve for separation of ganglion cell 
(GC) and cone density, and cone:GC ratio to detect glaucoma. 
Area under the ROC curve (AUROC) was 0.79 (95% confidence interval [CI] 0.71-
0.86) for both GC density and cone:GC ratio. Sixty-nine locations of glaucoma patients 
were included and compared to 75 locations of healthy controls.  
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Figure 7. Example of a 47 year-old female patient with normal-tension glaucoma.  
A – A large area of inferior ganglion cell (GC) loss and corresponding dense superior 
field defect (pattern deviation plot) are evident (nerve fibre bundle defect marked with 
black lines).  
B – Raw cone images for all 4 locations (cropped to ~2.89° x 2.89°, 740 x 740 pixels). 
Note blurred scans in the inferior retina with advanced retinal nerve fiber and ganglion 
cell loss (black arrows show dark patches where cones cannot be resolved). 
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Table 1. Demographic Data of Glaucoma Patients and Healthy Participants 
 Healthy Glaucoma P value 
n of eyes/participants 20/20 20/20  
Age, years 57.00 [51.25, 63.75] 54.00 [50.25, 59.75] 0.58 
Sex   0.74 
   male 6 (30) 8 (40)  
   female 14 (70) 12 (60)  
Eye   1.00 
   right 16 (80) 15 (75)  
   left 4 (20) 5 (25)  
BCVA, Snellen   0.06 
    6/5 20 (100) 15 (75)  
    6/6 0 (0) 4 (20)  
    6/9 0 (0) 1 (5)  
Spherical error, DS +0.50 [-1.25, +0.94] +0.13 [-1.38, +0.94] 0.68 
Astigmatism, DC -0.25 [-0.50, +0.00] -0.75 [-1.00, -0.50] 0.003 
IOP, mmHg 14.5 [13.3, 16.0] 13.0 [11.0, 15.0] 0.07 
RNFL thickness, µm 98.0 [92.0, 102.0] 68.5 [57.8, 78.0] <0.001 
Data are absolute vales (%), median [interquartile range] as appropriate. 
Abbreviations: BCVA best-corrected visual acuity, DC dioptre cylinder, DS dioptre sphere, IOP 
intraocular pressure, MD mean defect, n number of eyes/participants, PSD pattern standard 
deviation, RNFL retinal nerve fiber layer. 
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Table 2. Cone Density, estimated GC Density and Cone:GC Ratio, GCL Thickness 
and Visual Sensitivity at different retinal locations 
 Healthy Glaucoma P value 
GCs/mm²    
   superior nasal 3023 [2550, 3713] 2483 [1995, 3119] 0.06 
   inferior nasal 2885 [2200, 3314] 971 [727, 2099] <0.001 
   superior temporal 3325 [2441, 4301] 2684 [2262, 3166] 0.09 
   inferior temporal 3373 [2670, 4034] 1458 [727, 2252] <0.001 
   All locations 3158 [2503, 4060] 2125 [971, 2763] <0.001 
Cones/mm²    
   superior nasal 7295 [6845, 7763] 7196 [6972, 7499] 0.91 
   inferior nasal 7213 [6842, 7777] 7332 [7082, 7965] 0.32 
   superior temporal 7098 [6996, 7352] 7238 [6968, 7685] 0.55 
   inferior temporal 7432 [6814, 7630] 7215 [6700, 7495] 0.39 
   All locations 7242 [6876, 7700] 7248 [6968, 7634] 0.79 
Cone:GC ratio    
   superior nasal 2.43:1 [1.78:1, 
2.76:1] 
2.94:1 [2.25:1, 4.44:1] 0.08 
   inferior nasal 2.48:1 [2.15:1, 
3.34:1] 
6.76:1 [3.73:1, 10.78:1] <0.001 
   superior temporal 2.13:1 [1.72:1, 
2.02:1] 
2.73:1 [2.22:1, 3.60:1] 0.07 
   inferior temporal 2.18:1 [1.81:1, 
2.56:1] 
5.24:1 [3.01:1, 10.45:1] <0.001 
   All locations 2.35:1 [1.83:1, 
2.82:1] 
3.51:1 [2.59:1, 6.81:1] <0.001 
GCL thickness, µm    
   superior nasal 31.0 [30.0, 33.0] 27.5 [22.0, 32.8] 0.08 
   inferior nasal 30.0 [29.0, 32.0] 21.0 [19.0, 23.5] <0.001 
   superior temporal 32.0 [29.0, 34.0] 29.0 [24.0, 32.0] 0.06 
   inferior temporal 32.5 [28.8, 35.0] 20.0 [17.0, 23.0] <0.001 
   All locations 30.8 [29.1, 33.3] 23.3 [21.0, 27.5] <0.001 
Visual sensitivity, dB†    
   superior nasal 32.7 [31.3, 33.2] 29.9 [28.6, 32.5] 0.005 
   inferior nasal 32.1 [31.3, 32.8] 24.5 [17.2, 27.5] <0.001 
   superior temporal 32.4 [31.5, 33.1] 31.3 [30.1, 32.8] 0.03 
   inferior temporal 31.8 [31.1, 32.1] 25.3 [20.5, 28.7]  <0.001 
   All locations 32.1 [31.4, 32.9] 28.6 [24.4, 30.9] <0.001 
Data are median [interquartile range] retinal locations at ~ 8.8° eccentricity. 
Abbreviations: GC ganglion cell, GCL ganglion cell layer, n number of locations,. 
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Note: Not all of the 4 locations for each glaucoma patient or healthy participant could be imaged 
with some locations therefore excluded. The majority of images (> 80%, 75 images included/80 total 
number of locations in healthy subjects and 69/80 in glaucoma patients) were, however, analyzed. 
In bold, significantly reduced GC density and visual field sensitivity, and increased cone:GC ratio 
mainly in the inferior retina. Cone count remains constant over all locations. Most of the glaucoma 
patients (90%) had glaucomatous defects in the superior hemifield. 
 
 
